查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288782

全球人口筛查市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Population Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 339 Pages | 商品交期: 最快1-2个工作天内

价格

据推测，到2030年，全球人口筛查市场的需求将从2022年的35.3百万美元达到近6757百万美元的市场规模，在2023-2030年的研究期间，复合年增长率为7.48%。

人口筛查是指对一大群人（通常是特定人群）进行系统测试，以确定是否存在某种疾病或健康状况。人口筛查的目标是在早期阶段发现疾病或状况，这时的治疗更有效，可以带来更好的健康结果。人口筛查可以涉及各种测试，包括血液测试、成像测试和身体检查。人口筛查项目的例子包括乳房X光检查（乳腺癌）、巴氏涂片检查（宫颈癌）和结肠镜检查（结肠癌）。人口筛查也可用于确定某些疾病的风险因素，如心脏病的胆固醇和血压筛查。人口筛查项目通常由医疗服务提供者或公共卫生机构组织和实施，通常由政府资金支持。人口筛查项目的设计和实施会因所针对的疾病或状况、被筛查人群的特征以及现有的筛查方法和技术而有所不同。虽然人口筛查是在早期阶段发现疾病和病症的有效方法，但它也可能有缺点。例如，一些筛查测试可能产生假阳性或假阴性的结果，导致不必要的担心或错过诊断。此外，一些人可能出于各种原因选择不参加筛查项目，包括缺乏机会或担心隐私或后续护理费用。

市场动态：

人口筛查项目可以帮助在早期阶段发现慢性病，这时的治疗更有效，因此在减少这些疾病的负担方面发挥了重要作用。技术和筛查方法的进步使人口筛查项目更准确、更有效、更经济。例如，新的成像技术和生物标志物测试正在使疾病得到更早和更准确的检测。世界各地的许多政府正在认识到人口筛查项目的重要性，并提供资金和支持以扩大这些项目。这正在推动人口筛查市场的增长。随着人们意识到人口筛查的好处，以及筛查项目的准确性和有效性的提高，这些项目的接受度和吸收率正在增加。随着人们寻求保持健康和预防疾病的发生，预防保健的趋势越来越强。人口筛查项目是预防保健的一个重要组成部分，因此对这些项目的需求正在增加。

该研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。此外，这些工具还对全球人口筛查市场的每个细分市场进行了全面评估。人口筛查行业的增长和趋势为这项研究提供了一个全面的方法。

区域分析：

本节涵盖了区域前景，强调了北美、欧洲、亚太、拉丁美洲、中东和非洲地区人口筛查市场的当前和未来需求。此外，该报告重点关注所有突出地区的个别应用部分的需求、估计和预测。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。人口筛选市场的主要参与者包括安捷伦科技公司、赛默飞世尔科技公司、QIAGEN、F. Hoffmann-La Roche Ltd.、Quest Diagnostics、Illumina Inc.、ARUP Laboratories、Novogene Co.Ltd., LGC Limited, Gene by Gene Ltd.这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如主要的合併和收购、未来的能力、伙伴关系、财务概况、合作、新产品的开发、新产品的推出以及其他发展。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 市场的亮点
  • 全球市场简介

第三章：人口普查 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场限制因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按地域分類的市场吸引力分析
    • 按产品分类的市场吸引力分析
    • 按业务分类的市场吸引力分析
    • 按性别分類的市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按年龄分類的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商名单
    • 关键原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：Covid-19爆发的影响分析

第六章：全球人口筛查市场分析：按地理区域划分

  • 按地理区域概述
  • 历史和预测数据
  • 按地理区域分析
  • 国家
  • 国家

第7章 ：全球人口筛查市场分析：按产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 硬件设备（仪器、套件、芯片）
  • 测试/实验室（服务）
  • 分析/解释（个性化和解释）

第八章：全球人口筛查市场分析：按业务分类

  • 按业务概述
  • 历史和预测数据
  • 按业务分析
  • 医院
  • 研究机构
  • 诊断实验室

第九章：全球人口筛查市场分析：按性别分类

  • 按性别概述
  • 历史和预测数据
  • 按性别分析
  • 男性
  • 女性

第十章：全球人口筛查市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 大众
  • 溢价

第十一章 ：全球人口筛查市场分析：按年龄

  • 按年龄分類的概述
  • 按年龄分類的
  • 历史和预测
  • 数据分析
  • 年龄<15岁按地区分類的历史和预测销售额
  • 15-65
  • 岁 65岁以上

第十二章 ：全球人口筛查市场销售分析：按地理区域划分

  • 区域展望
  • 简介
  • 北美洲销售分析
    • 概述、历史和预测销售分析
    • 北美地区分部销售分析
    • 北美地区国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概况、历史和预测的销售分析
    • 欧洲分部销售分析
    • 欧洲国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概况、历史和预测的销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉美地区销售分析
    • 概况、历史和预测的销售分析
    • 拉美地区分部销售分析
    • 拉美地区国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概况、历史和预测销售分析
    • 中东和非洲地区分部销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 其他中东和非洲国家销售分析

第十三章 ：人口筛查公司的竞争格局

  • 人口筛查市场竞争
  • 伙伴关系/合作/协议
  • 合併和收购
  • 新产品发布
  • 其他方面的发展

第14章：公司简介

  • 顶级公司份额分析
  • 市场集中度
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • QIAGEN
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • F. Hoffmann-La Roche Ltd.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Quest Diagnostics
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Illumina Inc.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • ARUP Laboratories
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Novogene Co. Ltd.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • LGC Limited
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展
  • Gene Gene Ltd.
    • 公司概览
    • 公司收入
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR112110525

The global demand for Population Screening Market is presumed to reach the market size of nearly USD 67.57 BN by 2030 from USD 35.3 BN in 2022 with a CAGR of 7.48% under the study period 2023-2030.

Population screening refers to the systematic testing of a large group of individuals, typically a specific population, to identify the presence of a particular disease or health condition. The goal of population screening is to detect the disease or condition at an early stage when treatment is more effective and can lead to better health outcomes. Population screening can involve a variety of tests, including blood tests, imaging tests, and physical exams. Examples of population screening programs include mammography screening (breast cancer, Pap smear screening (cervical cancer), and colonoscopy screening(colon cancer). Population screening can also be used to identify risk factors for certain diseases, such as cholesterol and blood pressure screening for heart disease. Population screening programs are typically organized and implemented by healthcare providers or public health agencies, often with support from government funding. The design and implementation of population screening programs can vary depending on the disease or condition being targeted, the characteristics of the population being screened, and the available screening methods and technology. While population screening can be an effective way to identify diseases and conditions at an early stage, it can also have drawbacks. For example, some screening tests can produce false-positive or false-negative results, leading to unnecessary worry or missed diagnoses. Additionally, some individuals may choose not to participate in screening programs for various reasons, including lack of access or concerns about privacy or the cost of follow-up care.

Market Dynamics:

Population screening programs can help to detect chronic diseases at an early stage, when treatment is more effective, and thus play an important role in reducing the burden of these diseases. Advances in technology and screening methods are making population screening programs more accurate, efficient, and cost-effective. For example, new imaging technologies and biomarker tests are enabling earlier and more accurate detection of diseases. Many governments around the world are recognizing the importance of population screening programs and are providing funding and support to expand these programs. This is driving the growth of the population screening market. As people become aware of the benefits of population screening and the accuracy and efficacy of screening programs improve, the acceptance and uptake of these programs are increasing. There is a growing trend towards preventive healthcare, as people seek to maintain their health and prevent the onset of diseases. Population screening programs are an important part of preventive healthcare, and the demand for these programs is therefore increasing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of population screening. The growth and trends of population screening industry provide a holistic approach to this study.

Market Segmentation:

This section of the population screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Geography

  • Nation
  • State

By Product

  • Hardware Equipment (Instrument, Kits, Chips)
  • Testing / Lab (Services)
  • Analytics / Interpretation (Personalization And Interpretation)

By Business

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

By Gender

  • Male
  • Female

By Type

  • Mass
  • Premium

By Age

  • Ages <15
  • 15-65
  • Ages 65+

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Population Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the population screening market include Agilent Technologies Inc., Thermo Fisher Scientific, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Quest Diagnostics, Illumina Inc., ARUP Laboratories, Novogene Co. Ltd., LGC Limited, Gene by Gene Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . POPULATION SCREENING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Geography
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Business
    • 3.7.4 Market Attractiveness Analysis By Gender
    • 3.7.5 Market Attractiveness Analysis By Type
    • 3.7.6 Market Attractiveness Analysis By Age
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY GEOGRAPHY

  • 6.1 Overview by Geography
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Geography
  • 6.4 Nation Historic and Forecast Sales by Regions
  • 6.5 State Historic and Forecast Sales by Regions

7 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Hardware Equipment (Instrument, Kits, Chips) Historic and Forecast Sales by Regions
  • 7.5 Testing / Lab (Services) Historic and Forecast Sales by Regions
  • 7.6 Analytics / Interpretation (Personalization And Interpretation) Historic and Forecast Sales by Regions

8 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY BUSINESS

  • 8.1 Overview by Business
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Business
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Research Institutes Historic and Forecast Sales by Regions
  • 8.6 Diagnostic Labs Historic and Forecast Sales by Regions

9 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY GENDER

  • 9.1 Overview by Gender
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Gender
  • 9.4 Male Historic and Forecast Sales by Regions
  • 9.5 Female Historic and Forecast Sales by Regions

10 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY TYPE

  • 10.1 Overview by Type
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Type
  • 10.4 Mass Historic and Forecast Sales by Regions
  • 10.5 Premium Historic and Forecast Sales by Regions

11 . GLOBAL POPULATION SCREENING MARKET ANALYSIS BY AGE

  • 11.1 Overview by Age
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Age
  • 11.4 Ages <15 Historic and Forecast Sales by Regions
  • 11.5 15-65 Historic and Forecast Sales by Regions
  • 11.6 Ages 65+ Historic and Forecast Sales by Regions

12 . GLOBAL POPULATION SCREENING MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE POPULATION SCREENING COMPANIES

  • 13.1. Population Screening Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF POPULATION SCREENING INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Agilent Technologies Inc.
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. Thermo Fisher Scientific Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. QIAGEN
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. F. Hoffmann-La Roche Ltd.
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Quest Diagnostics
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Illumina Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. ARUP Laboratories
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Novogene Co. Ltd.
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments
  • 14.11. LGC Limited
    • 14.11.1. Company Overview
    • 14.11.2. Company Revenue
    • 14.11.3. Products
    • 14.11.4. Recent Developments
  • 14.12. Gene Gene Ltd.
    • 14.12.1. Company Overview
    • 14.12.2. Company Revenue
    • 14.12.3. Products
    • 14.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Geography (USD MN)
  • Nation Market Sales by Geography (USD MN)
  • State Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Hardware Equipment (Instrument, Kits, Chips) Market Sales by Geography (USD MN)
  • Testing / Lab (Services) Market Sales by Geography (USD MN)
  • Analytics / Interpretation (Personalization And Interpretation) Market Sales by Geography (USD MN)
  • Analysis by Business (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Diagnostic Labs Market Sales by Geography (USD MN)
  • Analysis by Gender (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • Mass Market Sales by Geography (USD MN)
  • Premium Market Sales by Geography (USD MN)
  • Analysis by Age (USD MN)
  • Ages <15 Market Sales by Geography (USD MN)
  • 15-65 Market Sales by Geography (USD MN)
  • Ages 65+ Market Sales by Geography (USD MN)
  • Global Population Screening Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Population Screening Report
  • Market Research Process
  • Market Research Methodology
  • Global Population Screening Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Geography
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Business
  • Market Attractiveness Analysis by Gender
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Age
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Geography (USD MN)
  • Nation Market Sales by Geography (USD MN)
  • State Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Hardware Equipment (Instrument, Kits, Chips) Market Sales by Geography (USD MN)
  • Testing / Lab (Services) Market Sales by Geography (USD MN)
  • Analytics / Interpretation (Personalization And Interpretation) Market Sales by Geography (USD MN)
  • Global Market Analysis by Business (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Research Institutes Market Sales by Geography (USD MN)
  • Diagnostic Labs Market Sales by Geography (USD MN)
  • Global Market Analysis by Gender (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Mass Market Sales by Geography (USD MN)
  • Premium Market Sales by Geography (USD MN)
  • Global Market Analysis by Age (USD MN)
  • Ages <15 Market Sales by Geography (USD MN)
  • 15-65 Market Sales by Geography (USD MN)
  • Ages 65+ Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.